Phase 1 ALK-positive Non-small Cell Lung Cancer trials recruiting now

All ALK-positive Non-small Cell Lung Cancer trials, every phase

Phase 1 ALK-positive Non-small Cell Lung Cancer trials

• A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
  NCT07491497 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• AQUA07 in Patients With ALK-Positive Non-Small Cell Lung Cancer
  NCT07617337 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
  NCT07784959 · Phase: Phase 1 · Ages: No age limits stated · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.